A review of the key issues associated with the commercialization of biobanks

T Caulfield; S Burningham; Y Joly; Z Master; M Shabani; P Borry; A Becker; M Burgess; K Calder; C Critchley; K Edwards; SM Fullerton; H Gottweis; R Hyde-Lay; J Illes; R Isasi; K Kato; J Kaye; B Knoppers; J Lynch; A McGuire; E Meslin; D Nicol; K O'Doherty; U Ogbogu; M Otlowski; D Pullman; N Ries; C Scott; M Sears; H Wallace; MH Zawati

Journal article

A review of the key issues associated with the commercialization of biobanks

T Caulfield, S Burningham, Y Joly, Z Master, M Shabani, P Borry, A Becker, M Burgess, K Calder, C Critchley, K Edwards, SM Fullerton, H Gottweis, R Hyde-Lay, J Illes, R Isasi, K Kato, J Kaye, B Knoppers, J Lynch Show all

Journal of Law and the Biosciences | OXFORD UNIV PRESS | Published : 2014

DOI: 10.1093/jlb/lst004

Download PDF

University of Melbourne Researchers

Jane Kaye Author

Grants

Awarded by European Commission

Funding Acknowledgements

Wewould like to thank AllerGen, the cbcf Tumor Bank, the CNTRP, Genome Alberta, the Stem Cell Network, and the Cancer Stem Cell Consortium for funding support. Thank you also to our colleagues at the Health Law Institute.